JB Chemicals & Pharmaceuticals is currently trading at Rs. 323.95, up by 4.50 points or 1.41% from its previous closing of Rs. 319.45 on the BSE.
The scrip opened at Rs. 330.00 and has touched a high and low of Rs. 330.00 and Rs. 321.75 respectively. So far 2,827 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 367.65 on 02-Feb-2017 and a 52 week low of Rs. 255.00 on 28-Sep-2017.
Last one week high and low of the scrip stood at Rs. 339.95 and Rs. 317.25 respectively. The current market cap of the company is Rs. 2,707.00 crore.
The promoters holding in the company stood at 55.84%, while Institutions and Non-Institutions held 17.43% and 26.73% respectively.
JB Chemicals & Pharmaceuticals (JBCPL) has received an approval from Medicines Authority of Malta for its manufacturing facilities at Panoli, Gujarat for tablets, capsules, liquids for internal use and semi-solids (i.e. topical preparations like Ointments, Creams and Gels). This approval is valid in entire European Union.
These approvals will not only help company increase its product basket for this market but will also boost contract manufacturing business, which is a focused business area. The company’s manufacturing facility at Daman already enjoys EU approval for tablets and lozenges dosage forms.
JB Chemicals & Pharmaceuticals (JBCPL) is engaged in manufacturing of pharmaceutical specialties in various dosage forms, herbal remedies, diagnostics, generic drugs, active pharmaceutical ingredients (APIs).
